Cerner Standard 2016 COPD Registry Requirements

Cerner Standard 2016 COPD Registry Requirements View Source Registry Name: Chronic Obstructive Pulmonary Disease Context Alias o Registry Identification Exclusion Inclusion o Measures Measure Name: Spirometry Evaluation INCLUSION CRITERIA EXCLUSION CRITERIA MET CRITERIA EXCEPTION CRITERIA Measure Name: Bronchodilator Therapy INCLUSION CRITERIA EXCLUSION CRITERIA MET CRITERIA EXCEPTION CRITERIA Measure Name: Corticosteroid Therapy INCLUSION CRITERIA EXCLUSION CRITERIA MET CRITERIA EXCEPTION CRITERIA Measure Name: Corticosteroid Therapy on Admission INCLUSION CRITERIA EXCLUSION CRITERIA MET CRITERIA EXCEPTION CRITERIA Measure Name: Influenza Vaccination - Full Season Measure Name: Influenza Vaccination - Partial Season Measure Name: Influenza Vaccination - Current Season Measure Name: Pneumonia Vaccination Measure Name: Pneumonia Vaccination - Comprehensive Measure Name: Tobacco Use Screening and Cessation Measure Name: Semiannual Office Visits o Components o Facts o Concepts

Registry Name: Chronic Obstructive Pulmonary Disease Summary The COPD registry will include persons in the population, aged 18 years and older, with a diagnosis of Chronic Obstructive Pulmonary Disorder (COPD), and at least one outpatient encounter in the current measurement period or prior two measurement periods. Context Alias Registry - Context ID Alias Name CERNER STANDARD dc45fd8c- Chronic 5877-46fa- Obstructive a9a7- CERNER_STANDARD_CHRONIC_OBSTRUCTIVE_PULMONARY_DISEASE Pulmonary b4ce8743af70 Disease Registry Identification Exclusion Exclusion Any one of the following: o Patient is deceased o OR Patient is in Hospice Care during the measurement period o OR Manual REGISTRY exclusions Exclusion Deceased OR HospiceCare OR ManualExclusion Inclusion

Inclusion Patient's age is 18 as of the last day of the current measurement AND Patient has an active diagnosis of COPD at any time prior to the end of the current measurement AND Patient had at least one of the following during the current measurement period or within the two previous measurement periods: o Outpatient Visit o OR Extended Care Visit Inclusion AgeGTE18 AND COPDDx AND (OutpatientVisit OR ExtendedCareVisit) Measures Measure Name 1. Spirometry Evaluation 2. Bronchodilator Therapy 3. Corticosteroid Therapy 4. Corticosteroid Therapy on Admission 5. Influenza Vaccination - Full Season 6. Influenza Vaccination - Partial Season 7. Influenza Vaccination - Current Season 8. Pneumonia Vaccination 9. Pneumonia Vaccination - Comprehensive 10. Tobacco Use Screening and Cessation 11. Semiannual Office Visit Measure Name: Spirometry Evaluation The proportion of persons in the COPD Registry population with documented spirometry testing to confirm a new diagnosis of COPD during the current measure References NQF #0577, NQF #0091, PQRS #51 Spirometry Evaluation Spirometry Evaluation INCLUSION CRITERIA

INCLUSION Inclusion NewCOPDDx Patients who have a new diagnosis of COPD during the current measurement EXCLUSION CRITERIA EXCLUSION Patients with a diagnosis of COPD OR Chronic Bronchitis anytime prior to the beginning of the current measurement Exclusion COPDDxPriorToMeasurementPeriod OR ChronicBronchitis MET CRITERIA MET Met SpirometryTesting EXCEPTION CRITERIA Patient has documentation of Spirometry Testing during the current measurement period. EXCEPTION Exception Measure Name: Bronchodilator Therapy The proportion of persons in the COPD Registry population with a diagnosis of COPD and documented FEV1/FVC < 60%, AND were prescribed an inhaled bronchodilator during the current measurement References NQF #0102, PQRS #52 Bronchodilator Therapy Bronchodilator Therapy INCLUSION CRITERIA INCLUSION Inclusion Any patient that had a FEV1/FVC < 60% during the current measurement

FEV1DividedByFVCLT60 EXCLUSION CRITERIA The patient has one or more of the following: EXCLUSION Bronchodilator Allergy at anytime prior to the end of the current measurement OR Bronchodilator Adverse Reaction at anytime prior to the end of the current measurement OR Exclusion Medical Reason during the current measurement Exclusion BronchodilatorAllergy OR BronchodilatorAdverseReaction OR BronchodilatorExclusionMedicalReason MET CRITERIA MET Patient was prescribed one or more of the following during the current measurement period: Inhaled Bronchodilator OR Inhaled Bronchodilator Prescribed CPTF Met InhaledBronchodilator OR BronchodilatorPrescribedCPTF EXCEPTION CRITERIA EXCEPTION Exception BronchodilatorExclusionPatientReason Measure Name: Corticosteroid Therapy Exclusion Patient Reason during the current measurement The proportion of persons in the COPD Registry population with an inpatient discharge or ED encounter, AND were prescribed a systemic corticosteroid during the current measurement References NQF #0549

Corticosteroid Therapy Corticosteroid Therapy INCLUSION CRITERIA INCLUSION All patients in the COPD registry that had a primary diagnosis of COPD during the measurement period from one of the following: Inpatient Visit OR An Emergency Visit If there is more than one encounter, use the most recent. Inclusion PrimaryCOPDDx AND (InpatientVisit OR EmergencyVisit) EXCLUSION CRITERIA The patient has one or more of the following: EXCLUSION Corticosteroid Allergy at anytime prior to the end of the current measurement OR Corticosteroid Adverse Reaction at anytime prior to the end of the current measurement OR Exclusion Medical Reason during the current measurement Exclusion CorticosteriodAllergy OR CorticosteroidAdverseReaction OR CorticosteroidExclusionMedicalReason MET CRITERIA MET Patient was prescribed a Systemic Corticosteroid or Systemic Corticosteroid Prescribed CPTF overlapping the 14 days from date of discharge, from one of the following during the current measurement period: Inpatient Visit with a primary diagnosis of COPD. OR An Emergency Visit with a primary diagnosis of COPD. Met SystemicCorticosteroidOverlap14DaysAfterDischarge AND (PrimaryCOPDDx AND (InpatientVisit OR EmergencyVisit))

EXCEPTION CRITERIA EXCEPTION Exception Measure Name: Corticosteroid Therapy on Admission References Polarity The proportion of persons in the COPD Registry population with an inpatient discharge or ED encounter, AND were prescribed a systemic corticosteroid within 5 days of admission during the current measurement Good Stratification Axis Limits Long Name Short Name Corticosteroid on Admission Corticosteroid on Admission INCLUSION CRITERIA INCLUSION All patients in the COPD registry that had a primary diagnosis of COPD during the measurement period from one of the following: Inpatient Visit OR An Emergency Visit If there is more than one encounter, use the most recent. Inclusion PrimaryCOPDDx AND (InpatientVisit OR EmergencyVisit) EXCLUSION CRITERIA The patient has one or more of the following: EXCLUSION Corticosteroid Allergy at anytime prior to the end of the current measurement OR Corticosteroid Adverse Reaction at anytime prior to the end of the current measurement OR Exclusion Medical Reason during the current measurement Exclusion

CorticosteriodAllergy OR CorticosteroidAdverseReaction OR CorticosteroidExclusionMedicalReason MET CRITERIA MET Patient was prescribed a Systemic Corticosteroid or Systemic Corticosteroid Prescribed CPTF overlapping the 5 days from date of admission, from one of the following during the current measurement period: Inpatient Visit with a primary diagnosis of COPD. OR an Emergency Visit with a primary diagnosis of COPD. Met SystemicCorticosteroidOverlap5DaysAfterAdmission AND (PrimaryCOPDDx AND (InpatientVisit OR EmergencyVisit)) EXCEPTION CRITERIA EXCEPTION Exception Measure Name: Influenza Vaccination - Full Season The proportion of persons in the COPD Registry population with a documented influenza vaccination, OR who reported receipt of an influenza vaccination between August 1 of the preceding calendar year to March 31 of the current calendar year. References NQF 41, ACO 14, PQRS 110 Influenza Vaccination - Full Season Influenza Vaccination - Full Season Influenza - Full Season Measure Name: Influenza Vaccination - Partial Season The proportion of persons in the COPD Registry population with a documented influenza vaccination, OR who reported receipt of an influenza vaccination between August 1 of the current calendar year to December 31 of the current calendar year. References NQF 41, ACO 14, PQRS 110

Polarity Good Influenza Vaccination - Partial Season Influenza Vaccination - Partial Season Influenza - Partial Season Measure Name: Influenza Vaccination - Current Season The proportion of persons in the COPD Registry population with a documented influenza vaccination, OR who reported receipt of an influenza vaccination between most recent August 1st and first March 31st after the most recent August 1st. References NQF 41, ACO 14, PQRS 110 Influenza Vaccination - Current Season Influenza Vaccination - Current Season Influenza - Current Season Measure Name: Pneumonia Vaccination The proportion of persons in the COPD Registry population with a documented pneumonia vaccination. References NQF 43, 617, 1653, ACO 15, PQRS 111 Pneumonia Vaccination Pneumonia Vaccination Pneumonia Vaccination Measure Name: Pneumonia Vaccination - Comprehensive The proportion of persons in the COPD Registry population with a documented pneumonia vaccination in alignment with age and/or medical condition requirements. References CDC Pneumonia Vaccination - Comprehensive CSR:Cerner Standard 2016 Pneumonia Vaccination Common Measure Requirements#Pneumonia Vaccination - Comprehensive

Pneumonia Vaccination - Comprehensive Measure Name: Tobacco Use Screening and Cessation The proportion of persons in the COPD Registry population with one or more tobacco use screen(s) documented, who received cessation counseling within the current measurement period or the prior measurement period, if identified as a tobacco user. References NQF #0027 and #0028 Polarity GOOD Tobacco Use Screening and Cessation Tobacco Use Screening and Cessation Tobacco Use Screening and Cessation Measure Name: Semiannual Office Visits References Polarity Sensitivity Proportion of persons in the COPD registry who have at least one outpatient encounter in the past six months. GOOD Semiannual Office Visit Semiannual Office Visit Semiannual Office Visit